Phase II trial of GEMOX for the advanced pancreatic cancer with family/personal history of HBOC related cancer

Background null A family and personal history of breast (B), ovarian(O), and pancreatic(P) cancer was reported to be a predictive marker in patients with pancreatic adenocarcinoma (PA) treated with platinum-based chemotherapy. We planned a prospective phase II trial to evaluate the efficacy and safety of platinum-based chemotherapy in this population. null null null Method null Eligible patients had chemotherapy-naive metastatic PA, had one or...